Live Seminar: Highly-multiplexed, High-resolution In Situ Assays using the MERSCOPE Platform with Vizgen (Friday June 2, 2023 10am - 12pm EST) [EXT]
Hi OCBN Team, We are looking to discussing the capabilities of the MERSCOPE platform with the Vizgen team and the Oral & Craniofacial Bionetwork on June 2 at 10am EST. We invite you to join us virtually to learn more about the assay if you have time and interst. All lab members are welcome. Field Applications Scientist Clare Sengupta will present a 40-minute session, followed by a 20-minute Q&A segment related to their highly-multiplexed, high-resolution in situ assays using the MERSCOPE Platform Clare has extensive experience in the field and is well-versed in MERSCOPE applications. She will have time to address any questions you may have during and after the presentation. Best, KMB ________________________________________________________________________________ Microsoft Teams meeting Join on your computer, mobile app or room device Click here to join the meeting<https://urldefense.proofpoint.com/v2/url?u=https-3A__teams.microsoft.com_l_meetup-2Djoin_19-253ameeting-5FY2Y0MWMwMGQtZDRjNi00NGU3LTkxZmYtYmFlYWFkZDZiYmZi-2540thread.v2_0-3Fcontext-3D-257b-2522Tid-2522-253a-25223162a5a4-2Db45c-2D4ebe-2Db8a9-2D707d06c65700-2522-252c-2522Oid-2522-253a-25224d91ff74-2D19a1-2D4eca-2D866b-2D19cfb5e55c2e-2522-257d&d=DwIFAw&c=D7ByGjS34AllFgecYw0iC6Zq7qlm8uclZFI0SqQnqBo&r=qoAiZkj_kNbZQGvS_D6Z4y2PfrZ4mhVsrrffr1rqcfM&m=1hzbvfp9WSv7hTDPEA109D5cRIuPVVReq4JcRCc-xN3-KSZ3tcdkdVIQqapRJi5R&s=YbFFghekBib2ahEhvGwPlwQozMWm7Q_Z7DITdBUrsOU&e= > Meeting ID: 237 535 918 928 Passcode: JbSPfd Download Teams<https://urldefense.proofpoint.com/v2/url?u=https-3A__www.microsoft.com_en-2Dus_microsoft-2Dteams_download-2Dapp&d=DwIFAw&c=D7ByGjS34AllFgecYw0iC6Zq7qlm8uclZFI0SqQnqBo&r=qoAiZkj_kNbZQGvS_D6Z4y2PfrZ4mhVsrrffr1rqcfM&m=1hzbvfp9WSv7hTDPEA109D5cRIuPVVReq4JcRCc-xN3-KSZ3tcdkdVIQqapRJi5R&s=289JZfaegEx2xdXkx3RvZkEjAZJ19jLEs6LBreKf6yY&e= > | Join on the web<https://urldefense.proofpoint.com/v2/url?u=https-3A__www.microsoft.com_microsoft-2Dteams_join-2Da-2Dmeeting&d=DwIFAw&c=D7ByGjS34AllFgecYw0iC6Zq7qlm8uclZFI0SqQnqBo&r=qoAiZkj_kNbZQGvS_D6Z4y2PfrZ4mhVsrrffr1rqcfM&m=1hzbvfp9WSv7hTDPEA109D5cRIuPVVReq4JcRCc-xN3-KSZ3tcdkdVIQqapRJi5R&s=lGrzGCPZeFzSBscdC6zt3fQ-Ij_mpyl94gFmx6qXsH0&e= > Learn More<https://urldefense.proofpoint.com/v2/url?u=https-3A__aka.ms_JoinTeamsMeeting&d=DwIFAw&c=D7ByGjS34AllFgecYw0iC6Zq7qlm8uclZFI0SqQnqBo&r=qoAiZkj_kNbZQGvS_D6Z4y2PfrZ4mhVsrrffr1rqcfM&m=1hzbvfp9WSv7hTDPEA109D5cRIuPVVReq4JcRCc-xN3-KSZ3tcdkdVIQqapRJi5R&s=tevf-ccDgTBiR93XlN7EWGbn4FCR1MzjfKfiAOSl-oM&e= > | Meeting options<https://urldefense.proofpoint.com/v2/url?u=https-3A__teams.microsoft.com_meetingOptions_-3ForganizerId-3D4d91ff74-2D19a1-2D4eca-2D866b-2D19cfb5e55c2e-26tenantId-3D3162a5a4-2Db45c-2D4ebe-2Db8a9-2D707d06c65700-26threadId-3D19-5Fmeeting-5FY2Y0MWMwMGQtZDRjNi00NGU3LTkxZmYtYmFlYWFkZDZiYmZi-40thread.v2-26messageId-3D0-26language-3Den-2DUS&d=DwIFAw&c=D7ByGjS34AllFgecYw0iC6Zq7qlm8uclZFI0SqQnqBo&r=qoAiZkj_kNbZQGvS_D6Z4y2PfrZ4mhVsrrffr1rqcfM&m=1hzbvfp9WSv7hTDPEA109D5cRIuPVVReq4JcRCc-xN3-KSZ3tcdkdVIQqapRJi5R&s=Y2zwOTWviVyjBpwBekII0vp4IkECxE0fu6epCw8CLIM&e= > ________________________________________________________________________________
participants (1)
-
Byrd, Kevin